Detalhe da pesquisa
1.
North American Blastic Plasmacytoid Dendritic Cell Neoplasm Consortium: position on standards of care and areas of need.
Blood
; 141(6): 567-578, 2023 02 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36399715
2.
Pivekimab sunirine (IMGN632), a novel CD123-targeting antibody-drug conjugate, in relapsed or refractory acute myeloid leukaemia: a phase 1/2 study.
Lancet Oncol
; 25(3): 388-399, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38423051
3.
Patterns of lower risk myelodysplastic syndrome progression: factors predicting progression to high-risk myelodysplastic syndrome and acute myeloid leukemia.
Haematologica
; 2024 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38299605
4.
Incidence of pleural effusion with dasatinib and the effect of switching therapy to a different TKI in patients with chronic phase CML.
Ann Hematol
; 103(6): 1941-1945, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38634915
5.
Flotetuzumab as salvage immunotherapy for refractory acute myeloid leukemia.
Blood
; 137(6): 751-762, 2021 02 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32929488
6.
Blastic Plasmacytoid Dendritic Cell Neoplasm.
J Natl Compr Canc Netw
; 21(5): 515-521, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37156483
7.
Acute Myeloid Leukemia, Version 3.2023, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 21(5): 503-513, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37156478
8.
Drivers of deep molecular response and long-term outcomes in patients with core binding factor acute myeloid leukemia.
Am J Hematol
; 98(12): E360-E363, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37705256
9.
Disease-related thrombocytopenia in myelofibrosis is defined by distinct genetic etiologies and is associated with unique prognostic correlates.
Cancer
; 128(19): 3495-3501, 2022 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35942592
10.
Molecular annotation of extramedullary acute myeloid leukemia identifies high prevalence of targetable mutations.
Cancer
; 128(21): 3880-3887, 2022 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36107670
11.
Splicing factor 3B subunit 1 (SF3B1) mutation in the context of therapy-related myelodysplastic syndromes.
Br J Haematol
; 198(4): 713-720, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35751140
12.
Tagraxofusp in Blastic Plasmacytoid Dendritic-Cell Neoplasm.
N Engl J Med
; 380(17): 1628-1637, 2019 04 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-31018069
13.
Fatigue Perpetuating Factors as Mediators of Change in a Cognitive Behavioral Intervention for Targeted Therapy-Related Fatigue in Chronic Myeloid Leukemia: A Pilot Study.
Ann Behav Med
; 56(2): 137-145, 2022 02 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33991085
14.
Correlates of fatigue severity in patients with chronic myeloid leukemia treated with targeted therapy.
Support Care Cancer
; 30(1): 87-94, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-34231041
15.
NCCN Guidelines Insights: Acute Myeloid Leukemia, Version 2.2021.
J Natl Compr Canc Netw
; 19(1): 16-27, 2021 01 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33406488
16.
Blastic plasmacytoid dendritic cell neoplasm: diagnosis, manifestations, and treatment.
Curr Opin Hematol
; 27(2): 103-107, 2020 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-31972688
17.
Internet-assisted cognitive behavioral intervention for targeted therapy-related fatigue in chronic myeloid leukemia: Results from a pilot randomized trial.
Cancer
; 126(1): 174-180, 2020 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31553815
18.
Safety and efficacy of CPX-351 in younger patients (<60 years old) with secondary acute myeloid leukemia.
Blood
; 141(12): 1489-1493, 2023 03 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-36493344
19.
Comparisons of commonly used front-line regimens on survival outcomes in patients aged 70 years and older with acute myeloid leukemia.
Haematologica
; 105(2): 398-406, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-31073071
20.
Favorable outcomes of acute leukemias of ambiguous lineage treated with hyperCVAD: a multi-center retrospective study.
Ann Hematol
; 99(9): 2119-2124, 2020 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-32676733